202 related articles for article (PubMed ID: 15007093)
1. Lysophosphatidic acid induces neointima formation through PPARgamma activation.
Zhang C; Baker DL; Yasuda S; Makarova N; Balazs L; Johnson LR; Marathe GK; McIntyre TM; Xu Y; Prestwich GD; Byun HS; Bittman R; Tigyi G
J Exp Med; 2004 Mar; 199(6):763-74. PubMed ID: 15007093
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR.
Cheng Y; Makarova N; Tsukahara R; Guo H; Shuyu E; Farrar P; Balazs L; Zhang C; Tigyi G
Cell Signal; 2009 Dec; 21(12):1874-84. PubMed ID: 19709640
[TBL] [Abstract][Full Text] [Related]
3. Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist.
McIntyre TM; Pontsler AV; Silva AR; St Hilaire A; Xu Y; Hinshaw JC; Zimmerman GA; Hama K; Aoki J; Arai H; Prestwich GD
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):131-6. PubMed ID: 12502787
[TBL] [Abstract][Full Text] [Related]
4. Thrombogenic and atherogenic activities of lysophosphatidic acid.
Siess W; Tigyi G
J Cell Biochem; 2004 Aug; 92(6):1086-94. PubMed ID: 15258894
[TBL] [Abstract][Full Text] [Related]
5. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists.
Davies SS; Pontsler AV; Marathe GK; Harrison KA; Murphy RC; Hinshaw JC; Prestwich GD; Hilaire AS; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 2001 May; 276(19):16015-23. PubMed ID: 11279149
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.
Li AC; Brown KK; Silvestre MJ; Willson TM; Palinski W; Glass CK
J Clin Invest; 2000 Aug; 106(4):523-31. PubMed ID: 10953027
[TBL] [Abstract][Full Text] [Related]
7. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo.
Yoshida K; Nishida W; Hayashi K; Ohkawa Y; Ogawa A; Aoki J; Arai H; Sobue K
Circulation; 2003 Oct; 108(14):1746-52. PubMed ID: 14504178
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
[TBL] [Abstract][Full Text] [Related]
9. Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy.
Bishop-Bailey D; Hla T; Warner TD
Circ Res; 2002 Aug; 91(3):210-7. PubMed ID: 12169646
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.
Hao F; Zhang F; Wu DD; An D; Shi J; Li G; Xu X; Cui MZ
Am J Physiol Cell Physiol; 2016 Dec; 311(6):C975-C984. PubMed ID: 27760754
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
Benton CR; Koonen DP; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heikkila JJ; Bonen A
J Physiol; 2006 May; 573(Pt 1):199-210. PubMed ID: 16484294
[TBL] [Abstract][Full Text] [Related]
12. Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process.
Pavan L; Tarrade A; Hermouet A; Delouis C; Titeux M; Vidaud M; Thérond P; Evain-Brion D; Fournier T
Carcinogenesis; 2003 Aug; 24(8):1325-36. PubMed ID: 12807721
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein.
Pontsler AV; St Hilaire A; Marathe GK; Zimmerman GA; McIntyre TM
J Biol Chem; 2002 Apr; 277(15):13029-36. PubMed ID: 11809750
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
[TBL] [Abstract][Full Text] [Related]
16. PPAR gamma activators induce growth arrest and process extension in B12 oligodendrocyte-like cells and terminal differentiation of cultured oligodendrocytes.
Roth AD; Leisewitz AV; Jung JE; Cassina P; Barbeito L; Inestrosa NC; Bronfman M
J Neurosci Res; 2003 May; 72(4):425-35. PubMed ID: 12704804
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells.
Bruemmer D; Yin F; Liu J; Berger JP; Kiyono T; Chen J; Fleck E; Van Herle AJ; Forman BM; Law RE
Mol Endocrinol; 2003 Jun; 17(6):1005-18. PubMed ID: 12677008
[TBL] [Abstract][Full Text] [Related]
20. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]